首页 > 最新文献

Advances in Pharmacology & Clinical Trials最新文献

英文 中文
The Effect of RBD-Based Vaccines on Covid-19 XBB 1.5 Subvariant 基于rbd的疫苗对Covid-19 XBB 1.5亚变体的影响
Pub Date : 1900-01-01 DOI: 10.23880/apct-16000213
M. Norizadeh
COVID-19 (Coronavirus disease 2019 or severe acute respiratory syndrome coronavirus 2) is a transmissible illness affected by a virus of the Coronaviridae family. Omicron is one of the COVID-19 variants of SARS-CoV-2 that firstly informed from Botswana B.1.1.529 was the original subvariant of omicron and then numerous sub-variants of Omicron have appeared comprising: BA.1, BA.2, BA.3, BA.4, and BA.5, BQ.1 and BQ.1.1, XBB.1, and XBB 1.5. The aim of this in silico research is to investigate the effect of monovalent (monovalent) vaccines on the XBB.1.5 variant. In this in silico study the sequence of spike protein obtained from NCBI and then the mutations of XBB 1.5 were add to obtained sequence. Since most of the currently used vaccines belong to the RBD region, in this study the RBD mutations were analyzed. All B cell and T cell epitopes of original strain (Wuhan) recorded and the epitopes that changed via mutation (XBB 1.5) were removed. The original virus has 10 B-cell epitopes in the RBD region. 5 of these epitopes were not mutated (unchanged. Besides the B cells epitopes, 45 alleles of T cell epitopes were also unchanged. The result of this study informed that the monovalent vaccine can produce humoral and especially cellular immunity and the vaccines help protect against severe illness, hospitalization, and death. The mutations will certainly reduce the effectiveness of monovalent vaccine, so the use of bivalent vaccines is recommended. Some countries do not have bivalent vaccines; these countries can still use monovalent vaccines.
COVID-19(冠状病毒病2019或严重急性呼吸综合征冠状病毒2)是一种由冠状病毒科病毒感染的传染性疾病。Omicron是SARS-CoV-2的COVID-19变体之一,最初来自博茨瓦纳B.1.1.529是Omicron的原始亚变体,随后出现了许多Omicron的亚变体,包括:BA.1, BA.2, BA.3, BA.4和BA.5, BQ.1和BQ.1.1, XBB.1和XBB 1.5。本硅片研究的目的是调查单价(单价)疫苗对XBB.1.5变种的影响。本文对从NCBI中获得的刺突蛋白序列进行了计算机化研究,并将XBB 1.5的突变添加到该序列中。由于目前使用的大多数疫苗属于RBD区域,因此本研究对RBD突变进行了分析。记录原株(武汉)的所有B细胞和T细胞表位,并去除经突变改变的表位(XBB 1.5)。原病毒在RBD区有10个b细胞表位。这些表位中有5个没有突变(不变)。除了B细胞表位外,T细胞表位的45个等位基因也没有改变。这项研究的结果表明,单价疫苗可以产生体液免疫,特别是细胞免疫,疫苗有助于预防严重疾病,住院和死亡。突变肯定会降低单价疫苗的有效性,因此建议使用二价疫苗。有些国家没有二价疫苗;这些国家仍然可以使用单价疫苗。
{"title":"The Effect of RBD-Based Vaccines on Covid-19 XBB 1.5 Subvariant","authors":"M. Norizadeh","doi":"10.23880/apct-16000213","DOIUrl":"https://doi.org/10.23880/apct-16000213","url":null,"abstract":"COVID-19 (Coronavirus disease 2019 or severe acute respiratory syndrome coronavirus 2) is a transmissible illness affected by a virus of the Coronaviridae family. Omicron is one of the COVID-19 variants of SARS-CoV-2 that firstly informed from Botswana B.1.1.529 was the original subvariant of omicron and then numerous sub-variants of Omicron have appeared comprising: BA.1, BA.2, BA.3, BA.4, and BA.5, BQ.1 and BQ.1.1, XBB.1, and XBB 1.5. The aim of this in silico research is to investigate the effect of monovalent (monovalent) vaccines on the XBB.1.5 variant. In this in silico study the sequence of spike protein obtained from NCBI and then the mutations of XBB 1.5 were add to obtained sequence. Since most of the currently used vaccines belong to the RBD region, in this study the RBD mutations were analyzed. All B cell and T cell epitopes of original strain (Wuhan) recorded and the epitopes that changed via mutation (XBB 1.5) were removed. The original virus has 10 B-cell epitopes in the RBD region. 5 of these epitopes were not mutated (unchanged. Besides the B cells epitopes, 45 alleles of T cell epitopes were also unchanged. The result of this study informed that the monovalent vaccine can produce humoral and especially cellular immunity and the vaccines help protect against severe illness, hospitalization, and death. The mutations will certainly reduce the effectiveness of monovalent vaccine, so the use of bivalent vaccines is recommended. Some countries do not have bivalent vaccines; these countries can still use monovalent vaccines.","PeriodicalId":313915,"journal":{"name":"Advances in Pharmacology & Clinical Trials","volume":"9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116929269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antibiotic Resistance Correlated to Patient Profile Factors in the Central Region of Romania 罗马尼亚中部地区抗生素耐药性与患者概况因素相关
Pub Date : 1900-01-01 DOI: 10.23880/apct-16000171
C. Dobrea
{"title":"Antibiotic Resistance Correlated to Patient Profile Factors in the Central Region of Romania","authors":"C. Dobrea","doi":"10.23880/apct-16000171","DOIUrl":"https://doi.org/10.23880/apct-16000171","url":null,"abstract":"","PeriodicalId":313915,"journal":{"name":"Advances in Pharmacology & Clinical Trials","volume":"72 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125491979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Psychotropic Drugs and Falls among Discharged Elderly Patients in Sana’a City, Yemen 也门萨那市老年出院患者精神药物及跌倒情况评价
Pub Date : 1900-01-01 DOI: 10.23880/apct-16000208
Ali Alyahawi
Background: In the elderly, falls are a common and important problem. One of the most feared consequences of falling is a hip fracture. Psychotropic drugs are used extensively among older people and there is a risk of falling that these drugs are used long-term and off-label. In addition to treatment of mental health problems such as depression, anxiety, and insomnia, with psychotropic drugs, these drugs are also prescribed to older patients for behavioral and psychological symptoms of dementia (BPSD). Aims of the study: To investigate whether psychotropic drugs are associated with an increased risk of fall injuries in older adults. Materials and Methods: A retrospective cross-sectional study was conducted on 170 discharge prescriptions of neurosurgery department from Mar 2022 to May 20202. In the present study, the elderly patients of 65 years and above were included in this study. The relevant data were collected from computerized records of a teaching hospital in Sana’a, Yemen. The prescriptions were evaluated and reviewed for investigate whether psychotropic drugs are associated with an increased risk of fall injuries. The obtained data was analyzed using descriptive statistics SPSS version 26. Categorical variables were presented as frequencies and percentages. Also, data were analyzed by chi-square test to know the relationship between the poly-pharmacy and major drug-drug interactions. A value of P-value > 0.05 was considered statistically significant. Results: A total of 170 discharge prescriptions were enrolled. 99 (58.3%) were male patients and 71 (41.8%) were female. It was showed that the major morbidity pattern was depression 79 (46.5). It had been found that (14 drugs) were drugs that generally should be avoided in older adults. The benzodiazepines were the most. The drugs that should be used with caution when prescribe to older adults were 6 drugs and the antidepressant SSRI was the most. Drugs to be avoided or dosage reduced with varying levels of kidney function were 3 drugs on discharge based on AGS 2019. According to the study results, 16.5% of patients had poly-pharmacy on discharge and 83.5% with no poly-pharmacy. The study results revealed that 62 (25.3%) of patients had at least one major drug-drug interactions on discharge. The most common drug-drug interaction was between antidepressant drugs (amitriptyline) with benzodiazepines (lorazepam) which result increase of falls and injuries. The relationship between poly-pharmacy at discharge and major drug-drug interaction was statistically significant in this study. Conclusion: This study showed a high prevalence of PIMs which are mostly psychotropic drugs that should be avoided or used with caution among older patients. Also, this study identifies the major drug-drug interactions that make falls and injures. Poly-pharmacy and chronic conditions were predictors for increased use of PIMs among older patients. Increase the knowledge about PIMs, psychotropic drugs and their poten
背景:在老年人中,跌倒是一个常见而重要的问题。跌倒最可怕的后果之一是髋部骨折。精神药物在老年人中广泛使用,这些药物长期使用和标签外使用有下降的风险。除了用精神药物治疗抑郁、焦虑和失眠等心理健康问题外,这些药物也被开给老年痴呆症(BPSD)的行为和心理症状患者。研究目的:调查精神药物是否与老年人跌倒伤害风险增加有关。材料与方法:对2022年3月至2020年5月神经外科170张出院处方进行回顾性横断面研究。本研究纳入65岁及以上的老年患者。相关数据是从也门萨那一家教学医院的计算机记录中收集的。对处方进行评估和审查,以调查精神药物是否与跌倒伤害风险增加有关。所得数据采用SPSS version 26描述性统计进行分析。分类变量以频率和百分比表示。采用卡方检验对数据进行分析,了解多重用药与主要药物相互作用之间的关系。p值> 0.05认为有统计学意义。结果:共纳入出院处方170张。其中男性99例(58.3%),女性71例(41.8%)。结果显示,主要发病类型为抑郁症79(46.5)。其中有14种药物是老年人一般应避免使用的药物。苯二氮卓类药物最多。老年人用药时应谨慎使用的药物有6种,其中抗抑郁药SSRI最多。根据AGS 2019,出院时应避免或减少不同肾功能的药物为3种。研究结果显示,16.5%的患者出院时多次服药,83.5%的患者出院时没有多次服药。研究结果显示,62例(25.3%)患者出院时至少有一种主要的药物-药物相互作用。最常见的药物-药物相互作用是抗抑郁药物(阿米替林)与苯二氮卓类药物(劳拉西泮)之间的相互作用,导致跌倒和受伤的增加。出院时多重用药与主要药物相互作用的关系在本研究中具有统计学意义。结论:老年患者中pim患病率高,以精神类药物为主,应避免或慎用。此外,这项研究还确定了导致跌倒和受伤的主要药物-药物相互作用。多种用药和慢性病是老年患者pim使用增加的预测因素。有必要提高患者和医疗保健提供者对精神药物、精神药物及其潜在副作用的认识。
{"title":"Evaluation of Psychotropic Drugs and Falls among Discharged Elderly Patients in Sana’a City, Yemen","authors":"Ali Alyahawi","doi":"10.23880/apct-16000208","DOIUrl":"https://doi.org/10.23880/apct-16000208","url":null,"abstract":"Background: In the elderly, falls are a common and important problem. One of the most feared consequences of falling is a hip fracture. Psychotropic drugs are used extensively among older people and there is a risk of falling that these drugs are used long-term and off-label. In addition to treatment of mental health problems such as depression, anxiety, and insomnia, with psychotropic drugs, these drugs are also prescribed to older patients for behavioral and psychological symptoms of dementia (BPSD). Aims of the study: To investigate whether psychotropic drugs are associated with an increased risk of fall injuries in older adults. Materials and Methods: A retrospective cross-sectional study was conducted on 170 discharge prescriptions of neurosurgery department from Mar 2022 to May 20202. In the present study, the elderly patients of 65 years and above were included in this study. The relevant data were collected from computerized records of a teaching hospital in Sana’a, Yemen. The prescriptions were evaluated and reviewed for investigate whether psychotropic drugs are associated with an increased risk of fall injuries. The obtained data was analyzed using descriptive statistics SPSS version 26. Categorical variables were presented as frequencies and percentages. Also, data were analyzed by chi-square test to know the relationship between the poly-pharmacy and major drug-drug interactions. A value of P-value > 0.05 was considered statistically significant. Results: A total of 170 discharge prescriptions were enrolled. 99 (58.3%) were male patients and 71 (41.8%) were female. It was showed that the major morbidity pattern was depression 79 (46.5). It had been found that (14 drugs) were drugs that generally should be avoided in older adults. The benzodiazepines were the most. The drugs that should be used with caution when prescribe to older adults were 6 drugs and the antidepressant SSRI was the most. Drugs to be avoided or dosage reduced with varying levels of kidney function were 3 drugs on discharge based on AGS 2019. According to the study results, 16.5% of patients had poly-pharmacy on discharge and 83.5% with no poly-pharmacy. The study results revealed that 62 (25.3%) of patients had at least one major drug-drug interactions on discharge. The most common drug-drug interaction was between antidepressant drugs (amitriptyline) with benzodiazepines (lorazepam) which result increase of falls and injuries. The relationship between poly-pharmacy at discharge and major drug-drug interaction was statistically significant in this study. Conclusion: This study showed a high prevalence of PIMs which are mostly psychotropic drugs that should be avoided or used with caution among older patients. Also, this study identifies the major drug-drug interactions that make falls and injures. Poly-pharmacy and chronic conditions were predictors for increased use of PIMs among older patients. Increase the knowledge about PIMs, psychotropic drugs and their poten","PeriodicalId":313915,"journal":{"name":"Advances in Pharmacology & Clinical Trials","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126823225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and Validation of Three Different UV Spectrophotometric Methods for Determination of New Antifungal Combination Used in Treatment of External Fungal Infections and Their Comparison Using ANOVA 三种不同紫外分光光度法测定体外真菌感染新复方抗真菌药物的建立与验证及其方差分析比较
Pub Date : 1900-01-01 DOI: 10.23880/apct-16000188
Ruchi Kansotia
Luliconazole and Terbinafine hydrochloride combination is used for external fungal infections and is newly introduced in market. Hence it is necessary to develop a appropriate method of analysis for rapid and accurate determination of these drugs. Three simple, sensitive, accurate, precise and economical UV-spectrophotometric methods (A,B,C) have been developed for simultaneous estimation of Luliconazole and Terbinafine hydrochloride in their pharmaceutical dosage form and their comparison by ANOVA. Method (A) is well based on first order derivative spectrophotometric method, in which zero crossing points for Luliconazole is 249.50 nm and Terbinafine hydrochloride is 258.50 nm. Linearity was found in range of 3-18 µg/ ml for both the drugs using methanol as a common solvent. Method (B) is constructed on the principle of dual wavelength method using absorbance difference at 281 and 306 nm for Luliconazole & 262 and 296 nm for Terbinafine hydrochloride. Method (C) is based on norm of Q-absorbance ratio method where iso-absorptive point was obtained at 250 nm and the λ max selected was of Terbinafine hydrochloride 282 nm. The developed methods were validated as per ICH guideline. Accuracy and precision of methods were determined and validated. All the developed methods showed good reproducibility and recovery with % RSD <2. These three methods developed were compared using one way ANOVA and the fcal value was found to be less than ftab value indicating that there is no significant difference in the assay results of the three methods. All three methods were found to be rapid, specific, precise and accurate and found no interferences from the cream excipients so it can be used for routine investigation of both drugs in quality control laboratories.
吕立康唑联合盐酸特比萘芬用于治疗体外真菌感染,是新上市的药物。因此,有必要开发一种合适的分析方法来快速准确地测定这些药物。建立了三种简便、灵敏、准确、精密度高、经济的紫外分光光度法(A、B、C),用于同时测定卢立康唑和盐酸特比萘芬的药物剂型,并通过方差分析进行比较。方法(A)基于一阶导数分光光度法,卢立康唑的零点交叉点为249.50 nm,盐酸特比萘芬的零点交叉点为258.50 nm。两种药物在3 ~ 18µg/ ml范围内均呈线性关系。方法(B)基于双波长法原理构建,卢立康唑的吸光度差为281 nm和306 nm,盐酸特比萘芬的吸光度差为262 nm和296 nm。方法(C)基于q -吸光度比法规范,在250 nm处获得等吸收点,λ max选择为盐酸特比萘芬282 nm。根据ICH指南对所开发的方法进行了验证。对方法的准确度和精密度进行了测定和验证。所有方法均具有良好的重现性和回收率,RSD <2。采用单因素方差分析对三种方法进行比较,发现ftab值小于ftab值,表明三种方法的测定结果无显著差异。三种方法均具有快速、特异、精密度高、准确度高的特点,且不受乳膏辅料的干扰,可用于两种药物在质控实验室的常规检测。
{"title":"Development and Validation of Three Different UV Spectrophotometric Methods for Determination of New Antifungal Combination Used in Treatment of External Fungal Infections and Their Comparison Using ANOVA","authors":"Ruchi Kansotia","doi":"10.23880/apct-16000188","DOIUrl":"https://doi.org/10.23880/apct-16000188","url":null,"abstract":"Luliconazole and Terbinafine hydrochloride combination is used for external fungal infections and is newly introduced in market. Hence it is necessary to develop a appropriate method of analysis for rapid and accurate determination of these drugs. Three simple, sensitive, accurate, precise and economical UV-spectrophotometric methods (A,B,C) have been developed for simultaneous estimation of Luliconazole and Terbinafine hydrochloride in their pharmaceutical dosage form and their comparison by ANOVA. Method (A) is well based on first order derivative spectrophotometric method, in which zero crossing points for Luliconazole is 249.50 nm and Terbinafine hydrochloride is 258.50 nm. Linearity was found in range of 3-18 µg/ ml for both the drugs using methanol as a common solvent. Method (B) is constructed on the principle of dual wavelength method using absorbance difference at 281 and 306 nm for Luliconazole & 262 and 296 nm for Terbinafine hydrochloride. Method (C) is based on norm of Q-absorbance ratio method where iso-absorptive point was obtained at 250 nm and the λ max selected was of Terbinafine hydrochloride 282 nm. The developed methods were validated as per ICH guideline. Accuracy and precision of methods were determined and validated. All the developed methods showed good reproducibility and recovery with % RSD <2. These three methods developed were compared using one way ANOVA and the fcal value was found to be less than ftab value indicating that there is no significant difference in the assay results of the three methods. All three methods were found to be rapid, specific, precise and accurate and found no interferences from the cream excipients so it can be used for routine investigation of both drugs in quality control laboratories.","PeriodicalId":313915,"journal":{"name":"Advances in Pharmacology &amp; Clinical Trials","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132774597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Sodium Valproate and Levetiracetam on Thyroid Hormones in Pediatric Patients with Epilepsy 丙戊酸钠和左乙拉西坦对小儿癫痫患者甲状腺激素的影响
Pub Date : 1900-01-01 DOI: 10.23880/apct-16000182
D. S
{"title":"Effect of Sodium Valproate and Levetiracetam on Thyroid Hormones in Pediatric Patients with Epilepsy","authors":"D. S","doi":"10.23880/apct-16000182","DOIUrl":"https://doi.org/10.23880/apct-16000182","url":null,"abstract":"","PeriodicalId":313915,"journal":{"name":"Advances in Pharmacology &amp; Clinical Trials","volume":"79 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128930184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Assessment of Drug Prescriptions at the University Hospital Center, National Center of Odontostomatology (CHU-CNOS) in Bamako, Mali 马里巴马科国家牙口腔医学中心(CHU-CNOS)大学医院中心药物处方评估
Pub Date : 1900-01-01 DOI: 10.23880/apct-16000186
Sanou Coulibaly Kho
Introduction: The prescription is an order for delivery and an act by which the practitioner draws up a list of products or hygienic-dietetic measures. Methodology: This is a cross-sectional, descriptive study to assess the quality of prescriptions. It took place at the University Hospital for Odontostomatology over a period of six months, during which 870 medical prescriptions were included. Result: The most important information to figured out orders such as the prescription date, the qualification of the prescriber, the signature and stamp were not mentioned, respectively, in 3; 81; 5 and 7% of cases. Almost no prescription prescribed referred to weights (99% of cases). The duration of treatment is not specified in 99% of cases. The full name of the patient and readability of orders were still noted in all cases. Discussion/Conclusion: For a prescription, certain legal references can incriminate prescribers and lead patients into therapeutic errors
处方是一种交付命令,是执业医师制定产品或卫生饮食措施清单的行为。方法:这是一项评估处方质量的横断面描述性研究。调查在大学口腔医院进行,为期6个月,其中包括870份医疗处方。结果:处方日期、开处方者资格、签章等对开处方最重要的信息在3中未被提及;81;5%和7%的病例。几乎没有处方提到体重(99%的病例)。99%的病例没有规定治疗的持续时间。在所有病例中,仍然注意到患者的全名和订单的可读性。讨论/结论:对于处方而言,某些法律参考可能会使开处方者入罪,导致患者出现治疗错误
{"title":"Assessment of Drug Prescriptions at the University Hospital Center, National Center of Odontostomatology (CHU-CNOS) in Bamako, Mali","authors":"Sanou Coulibaly Kho","doi":"10.23880/apct-16000186","DOIUrl":"https://doi.org/10.23880/apct-16000186","url":null,"abstract":"Introduction: The prescription is an order for delivery and an act by which the practitioner draws up a list of products or hygienic-dietetic measures. Methodology: This is a cross-sectional, descriptive study to assess the quality of prescriptions. It took place at the University Hospital for Odontostomatology over a period of six months, during which 870 medical prescriptions were included. Result: The most important information to figured out orders such as the prescription date, the qualification of the prescriber, the signature and stamp were not mentioned, respectively, in 3; 81; 5 and 7% of cases. Almost no prescription prescribed referred to weights (99% of cases). The duration of treatment is not specified in 99% of cases. The full name of the patient and readability of orders were still noted in all cases. Discussion/Conclusion: For a prescription, certain legal references can incriminate prescribers and lead patients into therapeutic errors","PeriodicalId":313915,"journal":{"name":"Advances in Pharmacology &amp; Clinical Trials","volume":"208 ","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133586764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Insulin in Prevention of Hypertrophic Scars 胰岛素在预防增生性瘢痕中的作用
Pub Date : 1900-01-01 DOI: 10.23880/apct-16000173
R. Chittoria
{"title":"Role of Insulin in Prevention of Hypertrophic Scars","authors":"R. Chittoria","doi":"10.23880/apct-16000173","DOIUrl":"https://doi.org/10.23880/apct-16000173","url":null,"abstract":"","PeriodicalId":313915,"journal":{"name":"Advances in Pharmacology &amp; Clinical Trials","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117110599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
DNA Binding Effect and Antibacterial Effect of Bezafibrate, an Antilipemic Agent 降脂剂贝扎贝特的DNA结合作用及抗菌作用
Pub Date : 1900-01-01 DOI: 10.23880/apct-16000176
I. Arman
{"title":"DNA Binding Effect and Antibacterial Effect of Bezafibrate, an Antilipemic Agent","authors":"I. Arman","doi":"10.23880/apct-16000176","DOIUrl":"https://doi.org/10.23880/apct-16000176","url":null,"abstract":"","PeriodicalId":313915,"journal":{"name":"Advances in Pharmacology &amp; Clinical Trials","volume":"4 3","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"120852617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Isolation and Biochemical Identification of Enterococcus Faecalis on Moribund Nile Tilapia (Oreochromis Niloticus L) 尼罗罗非鱼死鱼粪肠球菌的分离及生化鉴定
Pub Date : 1900-01-01 DOI: 10.23880/apct-16000177
Alvin T Reyes
{"title":"Isolation and Biochemical Identification of Enterococcus Faecalis on Moribund Nile Tilapia (Oreochromis Niloticus L)","authors":"Alvin T Reyes","doi":"10.23880/apct-16000177","DOIUrl":"https://doi.org/10.23880/apct-16000177","url":null,"abstract":"","PeriodicalId":313915,"journal":{"name":"Advances in Pharmacology &amp; Clinical Trials","volume":"4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124758864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Secondary Prevention of Coronary Heart Disease and PCSK9 Inhibitors 冠心病的二级预防和PCSK9抑制剂
Pub Date : 1900-01-01 DOI: 10.23880/apct-16000187
Kuznetsov Andrey
{"title":"Secondary Prevention of Coronary Heart Disease and PCSK9 Inhibitors","authors":"Kuznetsov Andrey","doi":"10.23880/apct-16000187","DOIUrl":"https://doi.org/10.23880/apct-16000187","url":null,"abstract":"","PeriodicalId":313915,"journal":{"name":"Advances in Pharmacology &amp; Clinical Trials","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131502815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Advances in Pharmacology &amp; Clinical Trials
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1